News

Aug 25
Micro S&P 500 Index Futures(MES1!),H4 Potential For Bearish Drop

Type: Bearish Drop Key Levels:Resistance: 4325.00Pivot: 4200.25Support: 3950.00 Preferred Case:On the H4, with price breaking out of the ascending channel and moving below the ichimoku indicator, we have a bearish bias that price will drop from the pivot at 4200.25 where the pullback resistance and 38.2% fibonacci retracement are to the 1st support at 3950.00 […]

Aug 25
Tesla shares up 2% premarket as they start trading on split-adjusted basis

Tesla Inc. shares TSLA, +0.22% were up 2.2% premarket Thursday, as they started trading on a split-adjusted basis, joining Alphabet Inc. GOOGL, -0.15%, Amazon.com Inc. amxn and other megacap companies dividing their stock this year. The EV maker’s board approved the 3-for-1 split on Aug. 5 and detailed the proposal to split on its proxy […]

Aug 25
Citi taking $170 mln in costs for winding down Russia retail business

Citigroup Inc. C, +0.12% said Thursday it’ll wind down its retail operation in Russia in a move that it expects will affect 2,300 and 15 branches, according to a filing. “Citi will also continue to actively pursue sales of certain Russian consumer banking portfolios,” the bank said. The move includes Citi’s deposits, investments, loans and […]

Aug 25
Malibu Boats rallies on stronger-than-expected profit, sales

Malibu Boats Inc. MBUU, +0.55% shares are rallying 7% in premarket trades Thursday after the company beat Wall Street’s profit and sales targets. The Loudon, Tenn., company said its fourth-quarter profit rose to $46.1 million, or $2.31 a share, from $33.44 million, or $1.60 a share, in the year-ago quarter. Adjusted income was $2.43 a […]

Aug 25
Abercrombie & Fitch swings to a loss, shares fall sharply

Abercrombie & Fitch Co. ANF, -5.57% fell 11% in premarket trades Thursday after the company said it lost $16.83 million, or 33 cents a share, in its second quarter, compared to a net income of $108.5 million, or $1.69 a share, in the year-ago quarter. Its adjusted loss in the latest quarter totaled 30 cents […]

Aug 25
Pfizer announces positive data from Phase 3 trial of older adults for bivalent RSV vaccine candidate

Pfizer Inc. PFE, -1.21% said Thursday a Phase 3 trial of older adults testing its bivalent RSV vaccine candidate achieved 85.7% efficacy in participants with more severe disease. RSV, or Respiratory Syncytial Virus, is a contagious virus that’s defined by a group of respiratory symptoms that vary from mild to more severe. The virus affects […]